Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E5501-G000-311 avatrombopag in chronic liver disease–related thrombocytopenia prior to elective procedures
CTR20140782Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avatrombopag in Thrombocytopenia, sponsored by Eisai Co., Ltd.. Started Dec 2014; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on CTR20140782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140782.